Pharmaceutical and biotech companies utilize pharmaceutical isolators extensively to prevent contamination during the production process. These machines work in accordance with the latest safety guidelines laid down by regulatory bodies. Regulatory compliance to maintain high sterility level in pharmaceutical products is a key factor driving the global pharmaceutical isolator market. High-potency active pharmaceutical ingredients (APIs) such as cytostatic, hormones, and antibiotics are prepared under very strict safety parameters where pharmaceutical isolators are ideally suited. They are progressively replacing traditional clean-rooms as they provide greater sterility assurance. This factor can take the global pharmaceutical isolators market ahead.
The global pharmaceutical isolator market stood at USD 20,876.4 Mn in 2017 and is estimated to attain a valuation of 32,944.3 Mn by the end of Forecast period. Pharmaceutical isolators are intended to provide absolute separation between the operator and end product to save the operator from the hazards associated with potent product handling. They also aid in the alleviation of risk of cross-contamination and to enhance the standard of drug. Pharmaceutical isolators are of utmost importance in the pharmaceutical industry, and the global pharmaceutical isolator market is likely to post a CAGR of 7.86% over the forecast period of 2018-2023, asserts Market Research Future (MRFR) in an in-depth study.
Pharmaceutical isolators are associated with advantages such as improved product quality and reduced operating costs. Pharmaceutical companies are increasingly realizing the benefits associated with pharmaceutical isolators due to which they have gained greater relevance in the pharmaceutical industry. They ensure a safe working environment for pharmaceutical operators regardless of them being in any process. Moreover, increasing R&D activities and growing amalgamation of aseptic processing of toxic compounds are other factors igniting growth within the global pharmaceutical isolators market.
Segmentation
The global pharmaceutical isolator market has been segmented based on type, pressure, application, and end user.
By type, the global pharmaceutical isolator market has been segmented into closed and open isolator. The open isolator segment is the dominant segment which accounts for 60.5% share of the global market. The open isolator segment can reach a valuation of USD 20,566.3 Mn at a CAGR of 8.56% over the forecast period.
By pressure, the global pharmaceutical isolator market has been segmented into positive and negative pressure. The positive pressure segment is the largest segment and holds almost 55.5% share of the market. The positive pressure segment is expected to advance with a CAGR of 8.42% while the negative pressure segment is expected to register a CAGR of 7.15% over the forecast period.
By application, the global pharmaceutical isolator market has been segmented into aseptic filling, fluid dispensing, sampling/weighing/distribution, product containment, and others. The aseptic filling segment is domineering the global market and can expect a CAGR of 8.37% while the fluid sampling segment is expected to attain the highest CAGR of 9.92% over the forecast period.
By end user, the global pharmaceutical isolator market has been segmented into pharmaceutical and biotechnological companies, hospitals, research & academic laboratories, and others. The pharmaceutical and biotechnological companies account for almost 45.8% share of the global market and are expected to expand at a CAGR of 8.13% over the forecast period. The research & academic laboratories segment is expected to capture the highest CAGR of 9.17% over the forecast period.
Request Free Sample: https://www.marketresearchfuture.com/sample_request/4683
Regional Analysis
By region, the global pharmaceutical isolator market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).
The Americas is at the forefront of the global pharmaceutical isolator market and is likely to maintain its lead over the forecast period. The pharmaceutical industry in the region is a frontrunner in the adoption of the latest technologies which foster market growth. The Americas market is likely to expand at a CAGR of 8.08% and reach USD 12,142.2 Mn by the end of 2023.
Europe is the second largest market for pharmaceutical isolators. The presence of a high number of research and academic institutes in the region who deploy pharmaceutical isolators boost the growth of the market. Europe market is estimated to grow with a CAGR of 7.31% over the forecast period.
APAC is the fastest growing market for pharmaceutical isolators and is expected to capture the highest CAGR of 8.73% over the forecast period. However, the MEA market is expected to exhibit sluggish growth and could reach USD 1,398.5 Mn by 2023.
Browse Complete Report:https://www.marketresearchfuture.com/reports/pharmaceutical-isolator-market-4683
Competitive Landscape
Skan AG (Switzerland), Azbil Telstar (Spain), Robert Bosch GmbH (Germany), Hosokawa Micron Ltd. (U.K.), Schematic Engineering Industries (India), Gelman Singapore Pte Ltd. (Singapore), COMECER S.P.A. (Italy), Getinge AB (Sweden), IsoTech Design (Canada), MBRAUN (Germany), NuAire Inc. (U.S.), VanRx Pharmasystems Inc. (Canada), Fedegari Autoclavi S.p.A (Italy), and LAF Technologies Pty Ltd. (Australia) are key players in the global pharmaceutical isolator market.
No comments:
Post a Comment